Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1233 participants.

Also called NCT02099110

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,233 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02099110
  • EudraCT 2013-003698-82
Main results
  • Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial Diabetes, obesity & metabolism, 2018-05 DOI, PubMed 29266675, PMC5947297 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02099110. Randomized; double masking; primary purpose treatment. Start 2014-04-22 (actual); primary completion 2016-05-26 (actual). Results posted on 2017-11-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Matching Placebo to Ertugliflozin 5 mg
Intervention (Drug)
Matching Placebo to Ertugliflozin 10 mg
Intervention (Drug)
Matching Placebo to sitagliptin 100 mg
Intervention (Drug)
Ertugliflozin 5 mg
Intervention (Drug)
Ertugliflozin 10 mg
Intervention (Drug)
Sitagliptin 100 mg
Intervention (Drug)
Metformin >= 1500 mg/day
Intervention (Biological)
Insulin Glargine Rescue Medication
Intervention (Drug)
Glimepiride Rescue Medication
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)
Collaborator
Pfizer (class: industry)

Record details

Record id
cardio:ct-nct02099110
Content hash
10eaef35b6c7cf829acdc93ed150d1676115e8d8dbdf0a81efd20fc6e867c99a